Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 15
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum]
Authors Thanawala S , Shah R , Somepalli V, Alluri KV , Desomayanandam P, Bhuvanendran A
Received 23 June 2023
Accepted for publication 23 June 2023
Published 27 June 2023 Volume 2023:15 Pages 63—65
Thanawala S, Shah R, Somepalli V, Alluri KV, Desomayanandam P, Bhuvanendran A. Clin Pharmacol. 2021;13:91–100.
The authors have informed the journal that on page 93, Table 2 “Efficacy Endpoints”, for the primary endpoint “Visual analogue scale after 80-m fast-paced walk test”, the parameter “Change from B to D45” is erroneously mentioned as −1.5 ± 0.4 where it should be −1.0 ± 0.4.
The correct Table 2 is:
On page 96, Table 3 “Biochemical and Inflammatory Markers”, for C-reactive protein, the unit is erroneously mentioned as (mg/dL), where it should be (mg/L).
The correct Table 3 is:
The authors advise these errors/corrections will not affect the previously shown results/conclusions and apologize for any confusion this may have caused.
 |
Table 2 Efficacy Endpoints |
 |
Table 3 Biochemical and Inflammatory Markers |
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.